Hyperbilirubinemia Treatment Market, Global Outlook and Forecast 2022-2028

February 2022 | 68 pages | ID: H8D9A399D73AEN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Hyperbilirubinemia Treatment in Global, including the following market information:

Global Hyperbilirubinemia Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Hyperbilirubinemia Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Phototherapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hyperbilirubinemia Treatment include Philips, GE Healthcare, Nice Neotech, Getinge Group and Solarc Systems, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hyperbilirubinemia Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hyperbilirubinemia Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hyperbilirubinemia Treatment Market Segment Percentages, by Type, 2021 (%)

• Phototherapy
• Exchange Transfusion
• Others

Global Hyperbilirubinemia Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hyperbilirubinemia Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Home Care

Global Hyperbilirubinemia Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hyperbilirubinemia Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hyperbilirubinemia Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Hyperbilirubinemia Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Philips
• GE Healthcare
• Nice Neotech
• Getinge Group
• Solarc Systems, Inc.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hyperbilirubinemia Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hyperbilirubinemia Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HYPERBILIRUBINEMIA TREATMENT OVERALL MARKET SIZE

2.1 Global Hyperbilirubinemia Treatment Market Size: 2021 VS 2028
2.2 Global Hyperbilirubinemia Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hyperbilirubinemia Treatment Players in Global Market
3.2 Top Global Hyperbilirubinemia Treatment Companies Ranked by Revenue
3.3 Global Hyperbilirubinemia Treatment Revenue by Companies
3.4 Top 3 and Top 5 Hyperbilirubinemia Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hyperbilirubinemia Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hyperbilirubinemia Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Hyperbilirubinemia Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hyperbilirubinemia Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Hyperbilirubinemia Treatment Market Size Markets, 2021 & 2028
  4.1.2 Phototherapy
  4.1.3 Exchange Transfusion
  4.1.4 Others
4.2 By Type - Global Hyperbilirubinemia Treatment Revenue & Forecasts
  4.2.1 By Type - Global Hyperbilirubinemia Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Hyperbilirubinemia Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Hyperbilirubinemia Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hyperbilirubinemia Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Home Care
5.2 By Application - Global Hyperbilirubinemia Treatment Revenue & Forecasts
  5.2.1 By Application - Global Hyperbilirubinemia Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Hyperbilirubinemia Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Hyperbilirubinemia Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hyperbilirubinemia Treatment Market Size, 2021 & 2028
6.2 By Region - Global Hyperbilirubinemia Treatment Revenue & Forecasts
  6.2.1 By Region - Global Hyperbilirubinemia Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Hyperbilirubinemia Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Hyperbilirubinemia Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Hyperbilirubinemia Treatment Revenue, 2017-2028
  6.3.2 US Hyperbilirubinemia Treatment Market Size, 2017-2028
  6.3.3 Canada Hyperbilirubinemia Treatment Market Size, 2017-2028
  6.3.4 Mexico Hyperbilirubinemia Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Hyperbilirubinemia Treatment Revenue, 2017-2028
  6.4.2 Germany Hyperbilirubinemia Treatment Market Size, 2017-2028
  6.4.3 France Hyperbilirubinemia Treatment Market Size, 2017-2028
  6.4.4 U.K. Hyperbilirubinemia Treatment Market Size, 2017-2028
  6.4.5 Italy Hyperbilirubinemia Treatment Market Size, 2017-2028
  6.4.6 Russia Hyperbilirubinemia Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Hyperbilirubinemia Treatment Market Size, 2017-2028
  6.4.8 Benelux Hyperbilirubinemia Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Hyperbilirubinemia Treatment Revenue, 2017-2028
  6.5.2 China Hyperbilirubinemia Treatment Market Size, 2017-2028
  6.5.3 Japan Hyperbilirubinemia Treatment Market Size, 2017-2028
  6.5.4 South Korea Hyperbilirubinemia Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Hyperbilirubinemia Treatment Market Size, 2017-2028
  6.5.6 India Hyperbilirubinemia Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Hyperbilirubinemia Treatment Revenue, 2017-2028
  6.6.2 Brazil Hyperbilirubinemia Treatment Market Size, 2017-2028
  6.6.3 Argentina Hyperbilirubinemia Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hyperbilirubinemia Treatment Revenue, 2017-2028
  6.7.2 Turkey Hyperbilirubinemia Treatment Market Size, 2017-2028
  6.7.3 Israel Hyperbilirubinemia Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Hyperbilirubinemia Treatment Market Size, 2017-2028
  6.7.5 UAE Hyperbilirubinemia Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Philips
  7.1.1 Philips Corporate Summary
  7.1.2 Philips Business Overview
  7.1.3 Philips Hyperbilirubinemia Treatment Major Product Offerings
  7.1.4 Philips Hyperbilirubinemia Treatment Revenue in Global Market (2017-2022)
  7.1.5 Philips Key News
7.2 GE Healthcare
  7.2.1 GE Healthcare Corporate Summary
  7.2.2 GE Healthcare Business Overview
  7.2.3 GE Healthcare Hyperbilirubinemia Treatment Major Product Offerings
  7.2.4 GE Healthcare Hyperbilirubinemia Treatment Revenue in Global Market (2017-2022)
  7.2.5 GE Healthcare Key News
7.3 Nice Neotech
  7.3.1 Nice Neotech Corporate Summary
  7.3.2 Nice Neotech Business Overview
  7.3.3 Nice Neotech Hyperbilirubinemia Treatment Major Product Offerings
  7.3.4 Nice Neotech Hyperbilirubinemia Treatment Revenue in Global Market (2017-2022)
  7.3.5 Nice Neotech Key News
7.4 Getinge Group
  7.4.1 Getinge Group Corporate Summary
  7.4.2 Getinge Group Business Overview
  7.4.3 Getinge Group Hyperbilirubinemia Treatment Major Product Offerings
  7.4.4 Getinge Group Hyperbilirubinemia Treatment Revenue in Global Market (2017-2022)
  7.4.5 Getinge Group Key News
7.5 Solarc Systems, Inc.
  7.5.1 Solarc Systems, Inc. Corporate Summary
  7.5.2 Solarc Systems, Inc. Business Overview
  7.5.3 Solarc Systems, Inc. Hyperbilirubinemia Treatment Major Product Offerings
  7.5.4 Solarc Systems, Inc. Hyperbilirubinemia Treatment Revenue in Global Market (2017-2022)
  7.5.5 Solarc Systems, Inc. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Hyperbilirubinemia Treatment Market Opportunities & Trends in Global Market
Table 2. Hyperbilirubinemia Treatment Market Drivers in Global Market
Table 3. Hyperbilirubinemia Treatment Market Restraints in Global Market
Table 4. Key Players of Hyperbilirubinemia Treatment in Global Market
Table 5. Top Hyperbilirubinemia Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hyperbilirubinemia Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hyperbilirubinemia Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hyperbilirubinemia Treatment Product Type
Table 9. List of Global Tier 1 Hyperbilirubinemia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hyperbilirubinemia Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hyperbilirubinemia Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hyperbilirubinemia Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hyperbilirubinemia Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hyperbilirubinemia Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hyperbilirubinemia Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hyperbilirubinemia Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Philips Corporate Summary
Table 31. Philips Hyperbilirubinemia Treatment Product Offerings
Table 32. Philips Hyperbilirubinemia Treatment Revenue (US$, Mn), (2017-2022)
Table 33. GE Healthcare Corporate Summary
Table 34. GE Healthcare Hyperbilirubinemia Treatment Product Offerings
Table 35. GE Healthcare Hyperbilirubinemia Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Nice Neotech Corporate Summary
Table 37. Nice Neotech Hyperbilirubinemia Treatment Product Offerings
Table 38. Nice Neotech Hyperbilirubinemia Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Getinge Group Corporate Summary
Table 40. Getinge Group Hyperbilirubinemia Treatment Product Offerings
Table 41. Getinge Group Hyperbilirubinemia Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Solarc Systems, Inc. Corporate Summary
Table 43. Solarc Systems, Inc. Hyperbilirubinemia Treatment Product Offerings
Table 44. Solarc Systems, Inc. Hyperbilirubinemia Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Hyperbilirubinemia Treatment Segment by Type in 2021
Figure 2. Hyperbilirubinemia Treatment Segment by Application in 2021
Figure 3. Global Hyperbilirubinemia Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hyperbilirubinemia Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hyperbilirubinemia Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hyperbilirubinemia Treatment Revenue in 2021
Figure 8. By Type - Global Hyperbilirubinemia Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hyperbilirubinemia Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hyperbilirubinemia Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hyperbilirubinemia Treatment Revenue Market Share, 2017-2028
Figure 12. US Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hyperbilirubinemia Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hyperbilirubinemia Treatment Revenue Market Share, 2017-2028
Figure 24. China Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hyperbilirubinemia Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hyperbilirubinemia Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hyperbilirubinemia Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Philips Hyperbilirubinemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. GE Healthcare Hyperbilirubinemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Nice Neotech Hyperbilirubinemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Getinge Group Hyperbilirubinemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Solarc Systems, Inc. Hyperbilirubinemia Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)